feedback

Course Director

Michael Postow, MD
Michael Postow, MD

Memorial Sloan Kettering Cancer Center
New York, New York

Faculty

Mario Sznol
Mario Sznol, MD

Yale Comprehensive Cancer Center & Smilow Cancer Center
New Haven, Connecticut

Marianne Davies
Marianne Davies, DNP, ACNP, AOCNP

Yale School of Nursing
Yale Comprehensive Cancer Center & Smilow Cancer Center
New Haven, Connecticut

Accredited by

Medical Learning Institute, Inc.

Activity Details

Credit Types:CME / CE
Credit Amount:1.5 Credits
Release Date:2017-Apr-06
Expiration Date:2018-Apr-07
Estimated Time for Completion:90 minutes
Registration Required:No
Cost:Free of Charge

Activity Description and Educational Objectives

How can we make the most of immunotherapy as the new pillar of cancer care? This activity based on the inaugural ASCO-SITC Clinical Immuno-Oncology Symposium 2017 in Orlando, Florida offers an essential immuno-oncology update to guide you in applying the evolving evidence to practice. Our experts elucidate what to expect from the use of immune checkpoint blockade therapies, and highlight best practices for appropriate immune-related response assessment and effective management of immune-related adverse effects. Based on this foundation, strategies for patient education and engagement, as well as collaborative, team-based care are discussed, which can help maximize the therapeutic potential of immunotherapies for the benefit of patients.

Upon completion of this activity, participants will be able to:
  • Describe the mechanisms of action of immune checkpoint inhibition in cancer therapy, and how immune system activation can lead to unique patterns of response to immunotherapy and development of irAEs
  • Characterize the spectrum and presentation of irAEs associated with immune checkpoint blockade therapies
  • Implement currently recommended irAE monitoring/detection parameters and management strategies in the context of team-based, multidisciplinary, patient-centric care
  • Educate patients with cancer about what to expect when undergoing immune checkpoint blockade therapy, including potential unique response patterns and irAEs, and the importance of communicating and collaborating with the clinical team to ensure timely detection and successful management of any irAEs that may emerge

Target Audience

This activity has been designed to meet the educational needs of academic and community oncologists, research oncologists, hematologist-oncologists, oncology advanced practice clinicians, and other healthcare professionals involved in the integration of immuno-oncology approaches into treatment of patients with cancer.

Nursing Education Purpose Statement

The purpose of this activity is to improve the knowledge and competence of nurses concerning the treatment or management of patients with various solid tumors using novel immune-based therapies.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. A score of 70% or higher is needed to obtain CME/CE credit. There are no pre-requisites and there is no fee to participate in this activity or to receive CME/CE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Enduring Material
Release and Expiration Dates: April 06, 2017 - April 05, 2018
Time to Complete: 90 minutes

Faculty & Disclosure / Conflict of Interest Policy

Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Medical Learning Institute, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and PVI, PeerView Institute for Medical Education do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CME/CE activity during the past 12 months.

Course Director and Moderator

Michael Postow, MD
Medical Oncologist
Memorial Sloan Kettering Cancer Center
New York, New York

Michael Postow, MD, has a financial interest/relationship or affiliation in the form of:
Grant/Research Support from Bristol-Myers Squibb.
Honoraria from Bristol-Myers Squibb and Merck & Co., Inc.
Advisory Board for Bristol-Myers Squibb and Novartis Pharmaceuticals Corporation.

Michael Postow, MD, does intend to discuss either non-FDA-approved or investigational use for the following products: immune checkpoint inhibitors and/or other immunotherapies.

Faculty

Mario Sznol, MD
Deputy Section Chief of Medical Oncology
Professor of Medicine
Co-Director, Yale SPORE in Skin Cancer
Co-Director, Melanoma Unit
Yale Comprehensive Cancer Center & Smilow Cancer Center
New Haven, Connecticut

Mario Sznol, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for AgonOx; Alexion; Arbutus Biopharma; AstraZeneca/Medimmune; Baxalta; Bristol-Myers Squibb; Eli Lilly and Company; Genentech, Inc./Roche; Inovio Pharmaceuticals, Inc.; Lycera; Merck & Co., Inc.; Modulate Therapeutics, Inc.; Nektar; Omniox; Pfizer; Seattle Genetics, Inc.; and Theravance Biopharma.
Advisory Board for Adaptimmune Therapeutics; Lion Biotechnologies, Inc.; Pieris Pharmaceuticals; and Symphogen Inc.
Other Financial or Material Support from Stock options in Adaptive Biotechnologies; Amphivena Therapeutics, Inc.; and Intensity Therapeutics.

Mario Sznol, MD, does intend to discuss either non-FDA-approved or investigational use for the following products: immune checkpoint inhibitors and/or other immunotherapies.

Marianne Davies, DNP, ACNP, AOCNP
Assistant Professor
Yale School of Nursing
Oncology Nurse Practitioner
Yale Comprehensive Cancer Center & Smilow Cancer Center
New Haven, Connecticut

Marianne Davies, DNP, ACNP, AOCNP, has a financial interest/relationship or affiliation in the form of:
Speakers Bureau participant with AstraZeneca; Bristol-Myers Squibb; Genentech, Inc.; and Merck & Co., Inc.

Marianne Davies, DNP, ACNP, AOCNP, does intend to discuss either non-FDA-approved or investigational use for the following products: immune checkpoint inhibitors and/or other immunotherapies.

CME Reviewer

Vijaya R. Bhatt, MD
University of Nebraska Medical Center
Omaha, Nebraska

Vijaya R. Bhatt, MD, has no financial interests/relationships or affiliations in relation to this activity.

Nurse Reviewer

Bobbie Perrin, RN, OCN
Oncology Nurse Navigator
Harrington Cancer Center
Amarillo, Texas

Bobbie Perrin, RN, OCN, has no financial interests/relationships or affiliations in relation to this activity.

Medical Director

Kadrin Wilfong, MD
PVI, PeerView Institute for Medical Education

Kadrin Wilfong, MD, has no financial interests/relationships or affiliations in relation to this activity.

Disclaimer

The information provided at this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.

Providership, Credit & Support

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. The Medical Learning Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Learning Institute, Inc. designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

Medical Learning Institute, Inc.
Provider approved by the California Board of Registered Nursing, Provider Number 15106, for 1.5 contact hour(s).

Providership

This CME/CE activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education.

Support

This activity is supported through educational grants from Bristol-Myers Squibb and Merck.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView Press or any of its partners, providers, and/or supporters.

Copyright © 2000-2017, PeerView Press - Medical Education Resource

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.